nicotinoyl-gaba has been researched along with gamma-aminobutyric acid in 9 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kresiun, VI; Rozhkovskiĭ, IaV | 1 |
| Aleksandrin, PN; Aleksandrin, VV; Gan'shina, TS; Kosoĭ, MIu; Mirzoian, RS | 1 |
| Gomita, Y; Goto, S; Ichimaru, Y; Matsuyama, K; Noda, A; Noda, H; Yamashita, C | 1 |
| Borisova, AO; Burov, IuV; Robakidze, TN | 1 |
| Borshchenko, SA; Danilov, VV; Danilova, TI; Medvedeva, IA | 1 |
| Chen, X; Cui, W; Zhan, Y; Zhang, Y; Zhang, Z; Zhong, D | 1 |
| Akopian, VP; Balian, LS; Zakarian, NA | 1 |
| Borodulina, IV; Vakhnina, NV; Zakharov, VV | 1 |
| Santillo, MF; Sprando, RL | 1 |
1 trial(s) available for nicotinoyl-gaba and gamma-aminobutyric acid
| Article | Year |
|---|---|
[Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo].
Topics: Brain Ischemia; gamma-Aminobutyric Acid; Ginkgo biloba; Humans; Neuroprotective Agents; Phytotherapy; Plant Extracts; Quality of Life | 2022 |
8 other study(ies) available for nicotinoyl-gaba and gamma-aminobutyric acid
| Article | Year |
|---|---|
[Molecular-biochemical mechanisms of the effects of nootropic agents].
Topics: Analgesics; Animals; Antioxidants; Brain; Cell Membrane; Erythrocytes; gamma-Aminobutyric Acid; Male; Piracetam; Rats; Rats, Inbred Strains; Stress, Physiological; Time Factors; Tranquilizing Agents | 1990 |
[Effect of pikamilon on the cortical blood supply and microcirculation in the pial arteriole system].
Topics: Animals; Arterioles; Cerebral Cortex; Electrodes, Implanted; gamma-Aminobutyric Acid; Male; Pia Mater; Rabbits; Rats; Time Factors; Vasodilation | 1989 |
Evaluation of isonicotinoyl-gamma-aminobutyric acid (GABA) and nicotinoyl-GABA as pro-drugs of GABA.
Topics: Animals; Behavior, Animal; Brain; Chemistry, Pharmaceutical; gamma-Aminobutyric Acid; Male; Mice | 1984 |
[Effect of amiridine on rat learning in a radial maze].
Topics: Aminoquinolines; Animals; Cholinesterase Inhibitors; gamma-Aminobutyric Acid; Learning; Male; Memory; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Tacrine | 1996 |
[Prospects for differentiated conservative treatment of patients with benign prostatic hyperplasia].
Topics: Adrenergic alpha-Antagonists; Aged; Antioxidants; Drug Combinations; gamma-Aminobutyric Acid; Humans; Hyperplasia; Male; Middle Aged; Minerals; Prostate; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Vitamins | 2001 |
Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Acetaminophen; Chemical Fractionation; Chromatography, Liquid; Drug Stability; gamma-Aminobutyric Acid; Humans; Linear Models; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
[Effect of nootropes on quantitative changes in the rat cerebral cortex GABA(A) receptor complexes under experimental hypokinesia conditions].
Topics: Animals; Cerebral Cortex; gamma-Aminobutyric Acid; Immobilization; Male; Nootropic Agents; Piracetam; Rats; Receptors, GABA-A; Time Factors | 2010 |
Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets.
Topics: gamma-Aminobutyric Acid; Nootropic Agents; Receptors, GABA-A | 2023 |